A comprehensive view of Women's Health Issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent
Published:
May 09, 2024
by Merck & Co. Inc.
|
Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers
Published:
May 08, 2024
by Merck & Co. Inc.
|
NY S04032: Relates to creating a private right of action for unconsented removal or tampering with a sexually protective device.
Published:
May 08, 2024
by New York 2023-2024 General Assembly
|
NY S06707: Provides that being eighteen years old or more, while in the course of committing rape in the first, second or third degree, criminal sexual act in the first, second or third degree, sexual...
Published:
May 08, 2024
by New York 2023-2024 General Assembly
|
IL SB3547: MAMMOGRAPHY PAMPHLET
Published:
May 08, 2024
by Illinois 103rd General Assembly
|
Ask us about our Transformation & Innovation market view